Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Human Hypertension|November 27, 2015
Renin angiotensinogen system gene polymorphisms and essential hypertension among people of West African descent: a systematic reviewL M Reiter, D L Christensen, A P GjesingMolecular Genetics and Metabolism|February 6, 2008
Association of the beta3-adrenergic receptor Trp64Arg polymorphism with common metabolic traits: studies of 7605 middle-aged white peopleA P Gjesing, G Andersen, K Borch-Johnsen, et al.Diabetologia|January 16, 2007
Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjectsA P Gjesing, G Andersen, K S Burgdorf, et al.Diabetic Medicine : a Journal of the British Diabetic Association|March 6, 2007
Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjectsA P Gjesing, G Andersen, A Albrechtsen, et al.Diabetologia|February 22, 2012
Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traitsA P Gjesing, C T Ekstrøm, H Eiberg, et al.Diabetologia|October 20, 2010
Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal testA P Gjesing, L L Kjems, M A Vestmar, et al.Diabetologia|September 29, 2011
Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individualsK S Burgdorf, A P Gjesing, N Grarup, et al.Diabetologia|November 17, 2007
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetesT Sparsø, G Andersen, T Nielsen, et al.Diabetologia|December 11, 2012
Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetesA Bonnefond, L Yengo, J Philippe, et al.Diabetologia|June 2, 2004
Large-scale studies of the HphI insulin gene variable-number-of-tandem-repeats polymorphism in relation to Type 2 diabetes mellitus and insulin releaseS K Hansen, A P Gjesing, S K Rasmussen, et al.Pageof 2